Bubs signs major deal with leading Chinese e-commerce platform

Bubs signs major deal with leading Chinese e-commerce platform

Bubs Australia (ASX: BUB) has partnered with leading Chinese e-commerce platform Alibaba to sell its products on the Tmall Global store.

Alibaba has 580 million monthly users across its different apps, with mother and baby products the second largest category on Alibaba, spearheaded by infant formula.

Bubs expects the Global Merchandise Value to be in excess of approximately $1 million in the first year of trading.

This is a major deal for the Australian infant milk formula producer and is expected to give them a larger footprint in China, according to founding managing director of Bubs Australia Kristy Carr.

"Alibaba is one of the largest retailers in the world," says Carr.

"This is therefore an important milestone in the evolution of our cross-border e-commerce strategy that will significantly broaden our reach to Chinese parents."

Carr says the group's unique market position and product offering will be a massive advantage when competing on the Chinese platform.

"As the only Australian vertically integrated producer of goat milk infant formula, we will be in a unique position to offer Chinese parents comfort that we have complete control over the quality and scalability of our supply chain back to the farm gate," says Carr.

"With this solid foundation in place, and with the support of the Alibaba team, we believe we are well positioned to establish a popular Flagship Store on Tmall Global."

The company has also made a significant step toward getting its product ready for the Chinese market after entering into a deal with Australia Deloraine Dairy (ADD).

ADD is one of only 15 licenced facilities in Australia authorised by Certification and Accreditation Administration of the People's Republic of China to produce infant formula products eligible for importation into China.

Bubs Australia chairman Dennis Lin says this is an important step to getting its products into China.

"This strategic partnership is a crucial step in achieving China Food and Drug Administration (CFDA) registration, enabling us to advance our China expansion strategy," says Lin.

"There is an increasing demand for goat milk based infant formula in China, especially in Mother and Baby stores. The Manufacturing Agreement will facilitate our CFDA registration and provide a defined pathway to maximising Bubs' access to 80,000 stores aligned with our partner QuanJaiWanPu, China's largest nationwide distributor of infant formula."

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Four ways businesses can use artificial intelligence to triumph in 2022
Partner Content
The last two years have delivered major disruption to the technology industry and broad...
PROS
Advertisement

Related Stories

Zip Co annual transaction volume tips over $10 billion mark

Zip Co annual transaction volume tips over $10 billion mark

Australian buy-now pay-later (BNPL) giant Zip Co (ASX: Z1P) is now ...

Pet Circle raises $125m to become Australia's latest unicorn

Pet Circle raises $125m to become Australia's latest unicorn

The dogs, cats, birds and fish that grace the pages of Pet Circle h...

Digital used car dealership Carma emerges from stealth with $28 million seed raise

Digital used car dealership Carma emerges from stealth with $28 million seed raise

Sydney-based online used car dealership Carma has today revealed a ...

Shipeezi pre-seed raise attracts logistics, tech experts as SaaS eyes future ASX listing

Shipeezi pre-seed raise attracts logistics, tech experts as SaaS eyes future ASX listing

Fast-growing supply chain management software company Shipeezi has ...